Cenova Touts Experience In Assessing Risk Of China Drug Development With Aslan Financing
This article was originally published in PharmAsia News
Executive Summary
Taking on the risk of a biotech investment in China takes experience, according to Shanghai-based Cenova Ventures, as a recent Series B finance round with Aslan Pharmaceuticals shows.